Pancreas Transplantation From Living Donors: A Single Center Experience of 20 Cases

Am J Transplant. 2016 Aug;16(8):2413-20. doi: 10.1111/ajt.13738. Epub 2016 Mar 10.

Abstract

Living donor pancreas transplantation (LDPT) has several advantages over deceased donor pancreas transplantation (DDPT), including better HLA matching, shorter ischemic time, and shorter waiting time. It remains an attractive option for diabetes mellitus (DM) patients with end stage renal disease. We reviewed 20 cases of LDPT performed in Asan Medical Center between October 1992 and March 2015. Six cases (30%) were pancreas transplantation alone (PTA), and the rest (70%) were simultaneous pancreas and kidney transplantation (SPK). Relations of donor and recipient were parents in 7 (35%), siblings in 6 (30%), spouse in 6 (30%), and cousin in 1 (5%). Graft survival in SPK at 1, 3, 5, and 10 years was 91.7%, 83.3%, 83.3%, and 83.3%, respectively, and that in PTA recipients was 50%, 33.3%, 16.7%, and 16.7%, respectively (p = 0.005). Causes of graft failure in SPK were thrombosis (one case), and rejection (one case), whereas those in PTA were noncompliance (two cases), thrombosis (one case), reflux pancreatitis (one case), and chronic rejection (one case). In terms of pancreas exocrine drainage, two grafts (25%) maintained their function in bladder drainage, while all grafts maintained in enteric drainage p < 0.05). Seven (35%) donors experienced minor pancreatic juice leakage and one underwent reoperation due to postoperative hematoma. Most donors maintained normoglycemia and normal renal function. However, two donors developed DM (at 1 and 90 months postdonation), and were treated with oral hypoglycemic agents. Graft survival in PTA recipients was poorer than in SPK due to poor compliance and bladder drainage-related problems. The surgical and metabolic complication rates of donors can be minimized by applying strict donor criteria. Therefore, LDPT with enteric drainage is an acceptable treatment for SPK.

Keywords: clinical research/practice; donors and donation: living; graft survival; pancreas/simultaneous pancreas-kidney transplantation.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Cadaver
  • Diabetes Mellitus, Type 1 / surgery*
  • Female
  • Follow-Up Studies
  • Graft Rejection / epidemiology*
  • Graft Survival
  • Humans
  • Incidence
  • Kidney Transplantation / methods*
  • Living Donors*
  • Male
  • Middle Aged
  • Pancreas Transplantation / methods*
  • Postoperative Complications*
  • Prognosis
  • Republic of Korea / epidemiology
  • Young Adult